Opportunity Information: Apply for CDC RFA GH16 1619
Apply for CDC RFA GH16 1619
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Western Region and Turkana County of the Republic of Kenya under the President’s Emergency Plan for AIDS R" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 04, 2015 and posted on Dec 04, 2015.
- Applicants must submit their applications by Feb 04, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $103,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Western Region and Turkana County of the Republic of Kenya is a U.S. government funding opportunity issued by the Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services (HHS), under the President's Emergency Plan for AIDS Relief (PEPFAR). The opportunity is structured as a discretionary cooperative agreement, meaning the award recipient would implement the program in close collaboration with CDC, with substantial technical involvement and ongoing programmatic engagement from the agency rather than a hands-off grant model. The announcement was posted on December 4, 2015, created the same day, and had a closing date of February 4, 2016.
The focus of the program is to strengthen and expand comprehensive HIV services in Kenya, specifically targeting the Western Region and Turkana County. The intent is not limited to a single clinical service; it emphasizes an integrated approach across prevention, testing, treatment, and long-term care. The announcement highlights work across general populations as well as key and priority populations, indicating an expectation that programming will be inclusive and tailored to groups at higher risk of acquiring or transmitting HIV, while still maintaining broad public health reach.
At the core of the program are several linked objectives that track closely with standard HIV epidemic control strategies. First, the program aims to increase knowledge of HIV status, which typically implies expanding and improving HIV testing services so more people know whether they are living with HIV and can be promptly linked to care. Second, it aims to prevent new HIV infections among both adults and children, reflecting a dual emphasis on primary prevention and on interventions that reduce transmission in family and community settings. Third, it seeks to provide high-quality care and antiretroviral therapy (ART) services, signaling expectations around clinical quality, continuity of care, and the practical ability to start and maintain patients on effective treatment. Finally, it targets achieving viral suppression, the key clinical and public health outcome associated with ART adherence and effective service delivery, because suppressed viral load improves individual health and significantly reduces the likelihood of onward transmission.
The ultimate outcome goal described in the funding opportunity is to decrease HIV incidence and reduce HIV-associated morbidity and mortality. In practice, that goal ties all earlier objectives together: broader testing increases case identification, prevention activities reduce exposure and transmission, strong clinical care and ART access reduce illness and death, and viral suppression drives population-level reductions in transmission. The fact that the opportunity specifies "high quality, sustainable and comprehensive" programming indicates the CDC expected the recipient not only to deliver services but to strengthen systems that can maintain performance over time, including program management, monitoring of outcomes, and strategies that support durable improvements in service delivery.
From a funding and scale perspective, the opportunity lists an award ceiling of $103,000,000 and anticipates a single award. That combination suggests a large, centralized implementing mechanism intended to coordinate or deliver services at significant scale across the named geographic areas. The CFDA number associated with the opportunity is 93.067, which corresponds to CDC HIV-related assistance programs, and the activity category is health. Eligibility is listed as "Others," with details referenced in an additional eligibility section of the original notice, implying that eligibility may have been limited or defined by specific organizational criteria not included in the excerpt provided.
In summary, this CDC PEPFAR cooperative agreement opportunity was designed to fund one large implementing partner to expand and strengthen HIV prevention, testing, care, and treatment services in Kenya's Western Region and Turkana County. The program aims to diagnose more people, prevent new infections in adults and children, deliver high-quality ART and ongoing care, and achieve viral suppression, with the broader public health aim of lowering new HIV infections and reducing HIV-related sickness and deaths.
Frequently Asked Questions (FAQs)
1) What is the name of this funding opportunity?
The opportunity is titled "Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Western Region and Turkana County of the Republic of Kenya."
2) Which U.S. government agency is offering this opportunity?
This is a U.S. government funding opportunity issued by the Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services (HHS).
3) Is this opportunity connected to PEPFAR?
Yes. The opportunity is issued under the President's Emergency Plan for AIDS Relief (PEPFAR).
4) What type of award is this (grant vs. cooperative agreement)?
The opportunity is a discretionary cooperative agreement. That structure indicates the recipient would implement the program in close collaboration with CDC, with substantial technical involvement and ongoing programmatic engagement from the agency (as opposed to a more hands-off grant model).
5) When was the announcement posted and when did it close?
The announcement was posted on December 4, 2015 (and created the same day). The closing date was February 4, 2016.
6) What geographic areas in Kenya are targeted?
The program specifically targets Kenya's Western Region and Turkana County.
7) What is the main purpose of the program?
The purpose is to strengthen and expand comprehensive HIV services in the targeted areas, using an integrated approach across prevention, testing, treatment, and long-term care.
8) Is the program focused on one service area (like testing only or treatment only)?
No. The announcement emphasizes an integrated approach that spans HIV prevention, HIV testing/knowledge of status, care, antiretroviral therapy (ART), and long-term treatment outcomes such as viral suppression.
9) Who is the program intended to serve?
The announcement highlights work across general populations as well as key and priority populations. This suggests programming is expected to be inclusive, while also being tailored to groups at higher risk of acquiring or transmitting HIV.
10) What are the core objectives described in the announcement?
The objectives are linked and align with HIV epidemic control strategies, including:
- Increasing knowledge of HIV status (typically through expanded and improved HIV testing services and linkage to care)
- Preventing new HIV infections among adults and children
- Providing high-quality HIV care and ART services
- Achieving viral suppression
11) What does "increase knowledge of HIV status" imply in practice?
Based on the announcement description, it implies expanding and improving HIV testing so more people learn their HIV status and can be promptly linked to care if they are living with HIV.
12) What does the prevention focus cover?
The announcement explicitly describes prevention of new HIV infections among both adults and children, indicating a dual emphasis on prevention efforts in the broader community and interventions that reduce transmission in family and community settings.
13) What does the opportunity say about HIV treatment services?
It calls for high-quality care and antiretroviral therapy (ART) services, signaling expectations around clinical quality, continuity of care, and the ability to start and maintain patients on effective treatment.
14) Why is viral suppression highlighted as a target?
Viral suppression is described as the key clinical and public health outcome associated with effective ART adherence and service delivery, because suppressed viral load improves individual health and significantly reduces the likelihood of onward HIV transmission.
15) What is the ultimate outcome goal of the program?
The opportunity states an ultimate goal of decreasing HIV incidence and reducing HIV-associated morbidity and mortality. The described approach links testing, prevention, treatment, and viral suppression to drive these outcomes.
16) What does "high quality, sustainable and comprehensive" mean in the context of this program?
As described, it indicates CDC expected the recipient not only to deliver services, but also to strengthen systems that can maintain performance over time. The description references elements such as program management, monitoring outcomes, and strategies that support durable improvements in service delivery.
17) How much funding is available under this opportunity?
The opportunity lists an award ceiling of $103,000,000.
18) How many awards were anticipated?
The announcement anticipates a single award, indicating a large, centralized implementing mechanism for the named geographic areas.
19) What is the CFDA number associated with this opportunity?
The CFDA number is 93.067.
20) What is the activity category for this opportunity?
The activity category is health.
21) Who is eligible to apply?
Eligibility is listed as "Others." The announcement notes that details are referenced in an additional eligibility section of the original notice, but those detailed criteria are not included in the information provided here.
22) What level of CDC involvement should an awardee expect?
Because this is a cooperative agreement, the awardee should expect substantial technical involvement and ongoing programmatic engagement from CDC, with implementation occurring in close collaboration with the agency.
23) What kind of implementing approach does the opportunity appear to support?
Based on the large ceiling amount and the expectation of one award, the opportunity appears designed to support one large implementing partner to coordinate or deliver HIV prevention, testing, care, and treatment services at significant scale across the Western Region and Turkana County.
Browse more opportunities from the same category: Health
Next opportunity: Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33)
Previous opportunity: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1619
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1619) also looked into and applied for these:
| Funding Opportunity |
|---|
| NHLBI Clinical Trial Pilot Studies (R34) Apply for PAR 16 037 Funding Number: PAR 16 037 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Pulmonary and Cardiovascular Consequences of Inhaled Nicotine (R01) Apply for RFA HL 17 008 Funding Number: RFA HL 17 008 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States Apply for RFA CK 16 005 Funding Number: RFA CK 16 005 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| Novel Genomic Technology Development Direct to Phase II SBIR (R44) Apply for PAR 16 017 Funding Number: PAR 16 017 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10) Apply for PAR 16 053 Funding Number: PAR 16 053 Agency: HHS-NIH11 Category: Health Funding Amount: $2,000,000 |
| Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific Apply for RFA IP 16 001 Funding Number: RFA IP 16 001 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $3,000,000 |
| Supporting the National Blood Transfusion Service (NBTS) in the implementation and strengthening of Blood Safety activities in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10260501SUPP16 Funding Number: CDC RFA PS10 10260501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $927,809 |
| National Child Traumatic Stress Initiative – Category III Community Treatment and Services (CTS) Centers Apply for SM 16 005 Funding Number: SM 16 005 Agency: HHS-SAMHS Category: Health Funding Amount: $400,000 |
| Implementation of Programs to Support Integration of Health Information Systems and HIV/AIDS/TB Treatment Services in the Republic of Zambia under the President’s Emergency Plan for AIDS (PEPFAR) Apply for CDC RFA GH16 1669 Funding Number: CDC RFA GH16 1669 Agency: HHS-CDC-CGH Category: Health Funding Amount: $10,000,000 |
| Enhanced surveillance in the Republic of Uganda under the President’s Emergency Plan for AIDS relief (PEPFAR) Apply for CDC RFA GH11 116505CONT16 Funding Number: CDC RFA GH11 116505CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Supporting the Scale up of Comprehensive HIV/AIDS Prevention Services in the Republic of Uganda under PEPFAR Apply for CDC RFA PS10 10200501SUPP16 Funding Number: CDC RFA PS10 10200501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $1,562,149 |
| Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND) Apply for HRSA 16 031 Funding Number: HRSA 16 031 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Precision Medicine Initiative Cohort Program Biobank (U24) Apply for RFA PM 16 004 Funding Number: RFA PM 16 004 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Strengthening Community-Based HIV/AIDS Prevention and Care Services in the Underserved Northern and Western Regions of the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10330501SUPP16 Funding Number: CDC RFA PS10 10330501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $3,470,000 |
| Novel Genomic Technology Development (R01) Apply for PAR 16 014 Funding Number: PAR 16 014 Agency: HHS-NIH11 Category: Health Funding Amount: $700,000 |
| Nurse Education, Practice, Quality and Retention – Bachelor of Science in Nursing Practicums in Community Settings Program Apply for HRSA 16 066 Funding Number: HRSA 16 066 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Reinforcing HIV Clinical Services within a Network of Public Health Institutions in the Central Plateau and the Lower Artibonite of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1712 Funding Number: CDC RFA GH16 1712 Agency: HHS-CDC-CGH Category: Health Funding Amount: $7,500,000 |
| International Centers of Excellence for Malaria Research (U19) Apply for RFA AI 15 056 Funding Number: RFA AI 15 056 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| Strengthening Epidemiology and Strategic Information in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1675 Funding Number: CDC RFA GH16 1675 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,010,000 |
| NHLBI Progenitor Cell Translational Consortium Coordinating Center (U24) Apply for RFA HL 16 022 Funding Number: RFA HL 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1619", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.